 |
|
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Shang-Chin Huang, Chun-Jen Liu
Clin Mol Hepatol. 2023;29(2):320-331. Published online 2023 Feb 1 DOI: https://doi.org/10.3350/cmh.2022.0422
|
|
Citations to this article as recorded by
 Pre-Existing and New-Onset Metabolic Dysfunctions Increase Cirrhosis and Its Complication Risks in Chronic Hepatitis B
Shang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, Sih-Han Liao, Shih-Jer Hsu, Chun-Ming Hong, Ting-Yuan Lan, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Jia-Horng Kao
American Journal of Gastroenterology.2025; 120(2): 401. CrossRef Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29‐year follow‐up
Ming‐Whei Yu, Wan‐Jung Wu, Chih‐Lin Lin, Chun‐Jen Liu, Wei‐Ya Peng, Pin‐Yu Huang, Yi‐Wen Huang, Jui‐Ting Hu, Hung‐Chuen Chang, Jyh‐Ming Liou
Hepatology Research.2025; 55(1): 46. CrossRef All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver disease
Shang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, Shih-Jer Hsu, Chun-Ming Hong, Ting-Yuan Lan, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Jia-Horng Kao
Journal of Hepatology.2025; 83(1): 43. CrossRef Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction
Ammara A Majeed, Amna S Butt
World Journal of Hepatology.2025;[Epub] CrossRef Impact of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease on Hepatocellular Carcinoma Incidence and Long-Term Prognosis Post-Liver Resection: A Systematic Review and Meta-Analysis
Qingyan Kong, Diao Kong, Bei Li, Wei Peng, Zheyu Chen
Academic Radiology.2025;[Epub] CrossRef Hepatocellular carcinoma surveillance after sustained virological response in chronic hepatitis C: Editorial on “Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-ana
Ho Soo Chun, Minjong Lee
Clinical and Molecular Hepatology.2025; 31(1): 261. CrossRef Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China
Di Shen, Xintian Cai, Junli Hu, Shuaiwei Song, Qing Zhu, Huimin Ma, Yingying Zhang, Rui Ma, Pan Zhou, Wenbo Yang, Jing Hong, Delian Zhang, Nanfang Li
Journal of Inflammation Research.2025; Volume 18: 1623. CrossRef Divergent roles of MASLD components in chronic hepatitis B: A double-edged sword
Shang-Chin Huang, Tung-Hung Su
Journal of Hepatology.2025; 83(1): e34. CrossRef Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
Toru Nakamura, Atsutaka Masuda, Dan Nakano, Keisuke Amano, Tomoya Sano, Masahito Nakano, Takumi Kawaguchi
Cells.2025; 14(6): 428. CrossRef Association of concomitant MASLD and hepatitis B virus with clinical prognosis in hepatocellular carcinoma after curative resection
Chih-Jan Ko
American Journal of Cancer Research.2025; 15(2): 737. CrossRef Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Clinical and Molecular Hepatology.2025; 31(Suppl): S182. CrossRef SLC22A1 Resists Hepatitis B Virus by Activating the JAK/STAT Pathway and Predicts the Effect of Pegylated Interferon α–Based Therapy on Chronic Hepatitis B
Huiying Yu, Bin Li, Huili Guo, Lin Li, Xiaoquan Liu, Lili Wu, Na Gao, Qiyi Zhao, Xiuqing Pang, Zhiliang Gao
The Journal of Infectious Diseases.2025;[Epub] CrossRef Safety of tenofovir alafenamide in the context of hyperlipidemia and cardiovascular diseases: a nationwide analysis
Jae-Young Kim, Hyuk Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
Hepatology International.2025;[Epub] CrossRef Non-invasive Assessment of Advanced Fibrosis and Steatosis in Chronic Hepatitis B Patients with Comorbid NAFLD
Zhenhua Zhou, Feng Chen, Rongrong Zou, Qianhui Li, Xiaomin Xu
Hepatitis Monthly.2025;[Epub] CrossRef Study on Ultrasound-Assisted Diagnosis of CHB Complicated with NAFLD Hepatic Fibrosis Based on Deep Learning
Xiuling Huang, Shan Huang, Changfeng Dong, Nuo Chen, Yuxuan Wang, Changmiao Wang, Yongquan Zhang, Cheng Feng
Journal of Imaging Informatics in Medicine.2025;[Epub] CrossRef Unraveling Demographic Patterns in Hepatitis B Clinical and Laboratory Profiles: Insights From a Ghanaian Cohort: A Retrospective Study
Napoleon Bellua Sam, Saeed Folorunsho Majeed, Adams Dramani
Health Science Reports.2025;[Epub] CrossRef Molecular mechanisms of pyroptosis in non-alcoholic steatohepatitis and feasible diagnosis and treatment strategies
Dong-fang Shang, Wen-qian Xu, Qing Zhao, Chen-lu Zhao, Si-ying Wang, Yong-li Han, He-guo Li, Ming-hao Liu, Wen-xia Zhao
Pharmacological Research.2025; 216: 107754. CrossRef Racing toward the future of chronic hepatitis B management: Achieving functional cure and enhancing hepatocellular carcinoma surveillance through precision medicine
Yaru Shi, Rong Fan
Interdisciplinary Medicine.2025;[Epub] CrossRef The Associations of Serum Folate Forms with Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Fibrosis: A Nationwide Cross-Sectional Study
Hai Zhao, Wei Fan, Yan Yan, Yuxing Liu, Xuejun Kang
Metabolites.2025; 15(6): 370. CrossRef Managing Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care Settings: A Review
Vignesh Rajan, Ambarish Das, J. Venkatachalam, K. K. Lohani, Chandrakant Lahariya
Preventive Medicine: Research & Reviews.2025;[Epub] CrossRef Usefulness of the Fibrosis‐4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients
Jun Inoue, Takehiro Akahane, Tomoo Kobayashi, Osamu Kimura, Kosuke Sato, Masashi Ninomiya, Tomoaki Iwata, Satoshi Takai, Norihiro Kisara, Toshihiro Sato, Futoshi Nagasaki, Masahito Miura, Takuya Nakamura, Teruyuki Umetsu, Akitoshi Sano, Mio Tsuruoka, Masa
Hepatology Research.2024; 54(2): 131. CrossRef The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review
Shang‐Chin Huang, Jia‐Horng Kao
The Kaohsiung Journal of Medical Sciences.2024; 40(1): 6. CrossRef Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion
Shang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, Chi-Ling Chen, Shih-Jer Hsu, Chen-Hua Liu, Sih-Han Liao, Chun-Ming Hong, Ting-Yuan Lan, Hung-Chih Yang, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
Clinical Gastroenterology and Hepatology.2024; 22(3): 581. CrossRef Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality
Sung Won Lee, Daniel Q. Huang, Ricki Bettencourt, Veeral Ajmera, Monica Tincopa, Nabil Noureddin, Maral Amangurbanova, Harris Siddiqi, Egbert Madamba, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Masato Yoneda, Ramzan I
Alimentary Pharmacology & Therapeutics.2024; 59(1): 80. CrossRef Metabolic dysfunction associated steatotic liver disease in patients with plaque psoriasis: a case–control study and serological comparison
Zheng Lin, Yue-yi Shi, Lu-yan Yu, Chen-xi Ma, Si-yi Pan, Yuan Dou, Qiu-jun Zhou, Yi Cao
Frontiers in Medicine.2024;[Epub] CrossRef The interplay of metabolic dysfunction‐associated fatty liver disease and viral hepatitis on liver disease severity: A large community‐based study in a viral endemic area
Chung‐Feng Huang, Po‐Cheng Liang, Pei‐Chien Tsai, Yu‐Ju Wei, Ching‐I Huang, Chih‐Wen Wang, Tyng‐Yuan Jang, Ming‐Lun Yeh, Po‐Yao Hsu, Ming‐Yen Hsieh, Yi‐Hung Lin, Chia‐Yen Dai, Wan‐Long Chuang, Jee‐Fu Huang, Ming‐Lung Yu
Journal of Gastroenterology and Hepatology.2024; 39(1): 193. CrossRef High prevalence of fatty liver and its association with metabolic syndrome among rural adults with chronic hepatitis C: Implications for primary healthcare
Ta-Jen Wang, Mei-Yen Chen, Yu-Chih Lin, Wen-Nan Chiu, Tung-Jung Huang, Hsu-Huei Weng
BMC Public Health.2024;[Epub] CrossRef Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC
Mei-Hsuan Lee, Yi-Ting Chen, Yu-Han Huang, Sheng-Nan Lu, Tsai-Hsuan Yang, Jee-Fu Huang, Szu-Ching Yin, Ming-Lun Yeh, Chung-Feng Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Hwai-I Yang, Hsuan-Yu Chen, Chien-Jen Chen
Clinical Gastroenterology and Hepatology.2024; 22(6): 1275. CrossRef Reply
Shang-Chin Huang, Tung-Hung Su, Jia-Horng Kao
Clinical Gastroenterology and Hepatology.2024; 22(9): 1957. CrossRef Current perspectives of viral hepatitis
Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou,
World Journal of Gastroenterology.2024; 30(18): 2402. CrossRef Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma
Xin Cai, Shi Peng, Xuan Xiao, Zhaoyang Huang, Pingan Zhang
Scientific Reports.2024;[Epub] CrossRef The overlap with metabolic dysfunction‐associated steatotic liver disease negatively affects outcomes of primary biliary cholangitis
María Hernández‐Pérez, Daniel Riado, Eva Pena, Carmen Méndez, Fernando Pinedo, Paloma Ramos, Pilar Castillo, Miriam Romero, Conrado Fernández‐Rodríguez, Antonio Olveira
Alimentary Pharmacology & Therapeutics.2024; 60(5): 613. CrossRef Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
Tyng‐Yuan Jang, Batbold Batsaikhan, Yo‐Chia Chen, Chia‐Yen Dai
Journal of Gastroenterology and Hepatology.2024; 39(11): 2327. CrossRef Response to the letter of HEPI-D-24–00252
Shang-Chin Huang, Tung-Hung Su, Jia-Horng Kao
Hepatology International.2024; 18(4): 1340. CrossRef Functional cure of chronic hepatitis B encounters resmetirom
Nai-Bin Yang, Wai-Kay Seto, Ming-Hua Zheng
Clinical and Molecular Hepatology.2024; 30(3): 580. CrossRef Hepatic macrophage niche: a bridge between HBV-mediated metabolic changes with intrahepatic inflammation
Jun Wang, Hongzhou Lu, Qian Li
Frontiers in Immunology.2024;[Epub] CrossRef Outcome of bariatric surgery in patients with unexpected liver cirrhosis: A multicenter study from China
Xia Sun, Libin Yao, Xing Kang, Weihua Yu, Fidele Kakule Kitaghenda, Mohammad Sajjad Ibn Rashid, Angeline Nogue Taguemkam, Jian Hong, Zhiyong Dong, Xitai Sun, Xiaocheng Zhu
Liver Research.2024; 8(3): 172. CrossRef Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinoma
Lung-Yi Mak
Journal of Liver Cancer.2024; 24(2): 145. CrossRef Comparison of Non-invasive Biochemical Fibrosis Markers According to Obesity-Based Metabolic Profile in Chronic Liver Disease with Chronic Hepatitis B Etiology
Sedat Çiftel
Ağrı Tıp Fakültesi Dergisi.2024; 2(3): 113. CrossRef Effect of dyslipidemia on HBsAg clearance in nucleos(t)ide analogues-experienced chronic hepatitis B patients treated with peginterferon alfa
Kaimin Song, Lan Ren, Yunyun Qian, Huitong Wang, Zhixiang Guo, Huatang Zhang, Yijie Lin, Yijuan Zheng, Dawu Zeng, Yongjun Zhou, Zhijun Su, Xueping Yu
BMC Infectious Diseases.2024;[Epub] CrossRef Effect of tenofovir versus entecavir on the long-term prognosis in hepatocellular carcinoma patients with concurrent metabolic dysfunction-associated steatotic liver disease and hepatitis B
Qingyan Kong, Qianqian Gao, Wenjie Li, Zheyu Chen
Asian Journal of Surgery.2024; 47(11): 4725. CrossRef Retrospective cohort evaluation study in terms of cardiovascular and metabolic diseases in chronic hepatitis B patients
Aysun Yakut
Frontiers in Endocrinology.2024;[Epub] CrossRef An insight into the updated pharmacotherapy of metabolic-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatohepatitis (MASH) in lean individuals: a review
Sanjay Bandyopadhyay, Shambo Samrat Samajdar, Sirshendu Chaudhuri, Saibal Das
Hospital Practice.2024; 52(4-5): 123. CrossRef Impact of concurrent MASLD on early-stage HCC following curative resection in chronic hepatitis B
Cao-Ngoc Huynh
American Journal of Cancer Research.2024; 14(9): 4567. CrossRef Obesity and risk for liver disease: a two-sample Mendelian randomisation study
Wen An, Jing Luo, Zhe Yu, Mengqi Li, Herui Wei, Aqian Song, Yuanpeng Mao, Hao Bian, Lingling He, Fan Xiao, Hongshan Wei
British Journal of Nutrition.2024; 132(10): 1403. CrossRef Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate
Shenglong Lin, Wanlong Huang, Ziyuan Liao, Huaxi Ma, Wenjun Wu, Minghua Lin, Defu Huang, Haibing Gao
Scientific Reports.2024;[Epub] CrossRef Revolutionizing the understanding of liver disease: Metabolism, function and future
Arnulfo E Morales-Galicia, Mariana M Ramírez-Mejía, Guadalupe Ponciano-Rodriguez, Nahum Méndez-Sánchez
World Journal of Hepatology.2024; 16(12): 1365. CrossRef Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Eileen Laurel Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(2): 371. CrossRef Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B
Shang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, Chi-Ling Chen, Shih-Jer Hsu, Sih-Han Liao, Chun-Ming Hong, Chen-Hua Liu, Ting-Yuan Lan, Hung-Chih Yang, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
Hepatology International.2023; 17(5): 1139. CrossRef Reply to: ‘A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted?’
Hyun Yang, Ji Hoon Kim, Ji Won Han, Soon Kyu Lee, Jeong Won Jang
Journal of Hepatology.2023; 79(4): e155. CrossRef Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Seong Gyu Hwang, Xuehong Zhang, Sang Hoon Ahn
International Journal of Cancer.2023; 153(8): 1448. CrossRef
|